The latest in a series of periodic roundups of drugs that have
moved from preclinical research into clinical testing via the
announcement of a Phase I trial or an application for a trial to
Finnish CRO Technical Research Center (VTT) has spun-off Zora
Biosciences, which becomes the only company in the Nordic region to
provide metabolomics services to pharma companies - a market with
Surface Logix has presented encouraging Phase 1 trial data for a
drug candidate that is being developed for the treatment of
abnormal levels of lipids in the bloodstream - a condition that
affects approximately 10 per cent of the...
A key study performed by US scientists has uncovered detailed
structural changes, which a catalytic enzyme undergoes in order to
carry out its biological function. The findings challenge
traditional hypothesis and may aid in future...
Applied Biosystems (AB) has given drug researchers a new software
application in thier quest to more quickly and accurately screen
drug candidates, which can be further developed into promising new
BioTrove and Blue Sky Biotech announce a collaborative effort to
provide a unique service solution, utilising mass
spectrometry-based high-throughput screening assays on previously
unscreenable drug targets.
A new robotic system, which provides data for genetic engineering,
provides an additional method in rapid mass screening to identify
new species as pharma becomes more open to using microorganisms as
living factories for producing...
A toxicology-on-a-chip tool, which can analyse drug candidates for
toxicity before they advance to pre-clinical stages, has taken one
step further towards commercialisation as the technology promises
to aid laboratory researchers...
Contract service provider, GeneLogic, has formed a partnership with
Millenium Pharmaceuticals acquiring a technology program and an
associated research team as part of the deal. Millenium becomes the
first customer for this new service...
Researchers in Finland and Belgium have developed a new way of
making plant-derived compounds in cell cultures that should cut the
cost of manufacturing a raft of pharmaceuticals, including drugs
Two $500m-plus licensing deals reveal the rewards available to
biotech firms with novel drugs, but also the lengths large
biopharma companies will now go to secure exclusive rights to
promising candidates, even if they are in the...
Switzerland's Tecan has introduced a range of laboratory automation
workstations, under the Freedom EVO banner, which are designed to
provide fluid handling applications in genomics, proteomics, drug
discovery and clinical diagnostics.
METabolic EXplorer, a French biotechnology company specialising in
the development and production of new biological processes for the
manufacturing of chemicals and pharmaceuticals, has bolstered its
scientific team with the appointment...